Results for tag: "Binge Eating Disorder Drug"

The Binge Eating Disorder Drug market is a subset of the Mental Disorders Drugs market. It is composed of pharmaceuticals used to treat Binge Eating Disorder (BED), a mental health disorder characterized by recurrent episodes of eating large amounts of food in a short period of time. BED is often accompanied by feelings of guilt, shame, and distress. Common treatments for BED include psychotherapy, lifestyle changes, and medications. The Binge Eating Disorder Drug market is composed of a variety of medications, including antidepressants, antipsychotics, and anticonvulsants. These medications are used to reduce the frequency and intensity of binge eating episodes, as well as to reduce associated symptoms such as depression and anxiety. Some companies in the Binge Eating Disorder Drug market include Eli Lilly, Pfizer, GlaxoSmithKline, and Johnson & Johnson. These companies produce a variety of medications used to treat BED, including fluoxetine, olanzapine, and topiramate. Show Less Read more